An Overview of the Stability and Delivery Challenges of Commercial Nucleic Acid Therapeutics

Nucleic acid (NA)-based biopharmaceuticals have emerged as promising therapeutic modalities. NA therapeutics are a diverse class of RNA and DNA and include antisense oligonucleotides, siRNA, miRNA, mRNA, small activating RNA, and gene therapies. Meanwhile, NA therapeutics have posed significant stab...

Descripción completa

Detalles Bibliográficos
Autores principales: Ingle, Rahul G., Fang, Wei-Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143938/
https://www.ncbi.nlm.nih.gov/pubmed/37111643
http://dx.doi.org/10.3390/pharmaceutics15041158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10143938/
https://www.ncbi.nlm.nih.gov/pubmed/37111643
http://dx.doi.org/10.3390/pharmaceutics15041158

Ejemplares similares